# Nuo Therapeutics, Inc.: Form 8-K, filed Sep 5, 2018

- Company: [Nuo Therapeutics, Inc.](/companies/aurx.md) (CIK 1091596)
- Form: 8-K
- Filed: 2018-09-05
- Accepted by EDGAR: Sep 5, 2018, 16:15 ET
- Period: 2018-09-04
- Accession: 0001437749-18-016613
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1091596/000143774918016613/aurx20180831_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1091596/000143774918016613/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1091596/000143774918016613/aurx20180831_8k.htm

Filed Sep 5, 2018.
Source: SEC EDGAR, the filing index for accession 0001437749-18-016613. Last ingested by Listed: Nov 14, 2026, 23:44 ET. No prices; not investment advice.
